Author

H. Y. Kim

Robert Koch InstituteORCID 0009-0005-9060-8953Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

H. Y. Kim4 papers

Biology Disciplines

Click to filter author papers

Systems Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 1 Research Focus:drug response / drug discovery· 1 Approach:statistical model· 1

Frequent Co-Authors

Craig W. HendrixiD· 1 shared Jessica Elizabeth HabereriD· 1 shared Lanxin ZhangiD· 1 shared Max von KleistiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

4 top collaborators · 6 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperSystems Biology

Craig W. HendrixORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Systems BiologybioRxivPreprintApr 15, 2024

Modeling of HIV-1 prophylactic efficacy and toxicity with islatravir shows non-superiority for oral dosing, but promise as a subdermal implant

H. Y. Kim, Lanxin Zhang, Craig W. Hendrix…·Max von Kleist

This paper models the efficacy and toxicity of islatravir as oral and subdermal PrEP, finding implants offer safer efficacy while oral dosing has toxicity risks.

DOI 10.1101/2024.04.15.589489

statistical modeldrug response / drug discovery

𝕏 PostBluesky